Bahaa Raya-Abu
950 West 28th Avenue
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420.
Journal: medRxiv : the preprint server for health sciences
Published: June 29, 2026
Long-acting monoclonal antibodies and the evolving landscape of infant respiratory syncytial virus prevention.
Journal: Pediatric investigation
Published: May 07, 2026
Case presentation of patients hospitalised with mpox (subclade Ib/2023sh) including children, adolescents, and adults in South Kivu, Democratic Republic of the Congo: an observational cohort study.
Journal: The Lancet. Infectious diseases
Published: October 21, 2025
Editorial: The immunological effects of respiratory viruses during pregnancy and breastfeeding.
Journal: Frontiers in immunology
Published: September 29, 2025
HKU1 immune imprinting is associated with post-COVID symptoms after SARS-CoV-2 infection.
Journal: iScience
Published: September 22, 2025
Correction: Riccò et al. Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options. Vaccines 2024, 12, 1317.
Journal: Vaccines
Published: July 24, 2025
Co-administration of vaccines in pregnancy: unique challenges and knowledge gaps.
Journal: Vaccine
Published: February 08, 2025
Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy.
Journal: Frontiers in immunology
Published: January 31, 2025
Title Not Found
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: November 25, 2024
Title Not Found
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: November 25, 2024
Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options.
Journal: Vaccines
Published: October 13, 2024
Nirsevimab to reduce infant morbidity from respiratory syncytial virus.
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: October 01, 2024
Last Updated: 09/26/2026